RSウイルス感染症の疫学的予測（～2024）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Upcoming Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.3 Global Trends 12
3.3.1 Preterm Infants and Children Born Preterm and Survived to Two Years of Age 13
3.3.2 Infants with Neonatal CLD 13
3.3.3 Children with Hemodynamically Significant Congenital Heart Disease 14
3.3.4 Children with Congenital Respiratory or Neuromuscular Diseases That Compromise Respiratory Function 15
3.3.5 Third-Trimester Pregnant Women 15
3.3.6 Hospitalizations for RSV Infection 16
3.4 Forecast Methodology 17
3.4.1 Sources Used 23
3.4.2 Sources Not Used 31
3.4.3 Forecast Assumptions and Methods 32
3.5 Epidemiological Forecast for RSV Infection (2014-2024) 41
3.5.1 Risk Groups for Severe RSV Infection in Children Less than Two Years 41
3.5.2 Preterm Births 47
3.5.3 Neonatal CLD 48
3.5.4 Third-Trimester Pregnant Women 49
3.5.5 RSV Hospitalizations in Children 50
3.6 Discussion 52
3.6.1 Epidemiological Forecast Insight 52
3.6.2 Limitations of the Analysis 54
3.6.3 Strengths of the Analysis 54
4 Appendix 56
4.1 Bibliography 56
4.2 About the Authors 64
4.2.1 Epidemiologists 64
4.2.2 Reviewers 64
4.2.3 Global Director of Therapy Analysis and Epidemiology 66
4.2.4 Global Head of Healthcare 66
4.3 About GlobalData 67
4.4 About EpiCast 67
4.5 Disclaimer 68